BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33285759)

  • 1. Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report.
    Cao L; Lv L
    Medicine (Baltimore); 2020 Dec; 99(49):e23503. PubMed ID: 33285759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK rearrangement in lung adenocarcinoma with concurrent cervix and breast metastases: A case report.
    Chuang X; Chen Y; Yu P; Qiu X; Wang J; Qu X; Teng Y; Liu Y; Jin B
    Thorac Cancer; 2018 Nov; 9(11):1513-1518. PubMed ID: 30144282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report.
    Fan J; Wu J; Huang B; Zhu Y; Shi H; Dai X; Nie X
    Diagn Pathol; 2020 May; 15(1):42. PubMed ID: 32375829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical metastatic breast localization in lung cancer].
    Serraille A; Barazzutti H; Greillier L; Barlesi F
    Rev Mal Respir; 2015 Nov; 32(9):953-5. PubMed ID: 26037683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK or ROS1-rearranged breast metastasis from lung adenocarcinoma: a report of 2 cases.
    Wu X; Wang H; Fang M; Li C; Zeng Y; Wang K
    Tumori; 2019 Dec; 105(6):NP67-NP71. PubMed ID: 31910790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
    Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
    BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.
    Gupta R; Amanam I; Rahmanuddin S; Mambetsariev I; Wang Y; Huang C; Reckamp K; Vora L; Salgia R
    Am J Clin Oncol; 2019 Apr; 42(4):337-344. PubMed ID: 30741758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast metastases from lung cancers with the EGFR mutation].
    Assouline P; Léger-Ravet MB; Saffroy R; Hamelin J; Bénissad A; Husleag P; Lemoine A; Oliviéro G
    Rev Mal Respir; 2017 Jan; 34(1):61-65. PubMed ID: 27282326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: A case report and literatures review.
    Jing X; Li F; Meng X; Liu Z; Yu J; Liu B
    Cancer Biol Ther; 2017 May; 18(5):279-284. PubMed ID: 28362192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].
    Caliez J; Monnet I; Pujals A; Rousseau-Bussac G; Jabot L; Boudjemaa A; Leroy K; Chouaid C
    Rev Mal Respir; 2017 May; 34(5):576-580. PubMed ID: 27646667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
    Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
    Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Whole-process Management of Treatment of Advanced ALK Positive Non-small Cell Lung Cancer: A Case Report].
    Bai H; Han Y; Niu Y; Zhang M
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):598-604. PubMed ID: 34344501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
    Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS; Patel PR; Curran WJ; Shu HG; Sica GL; Higgins KA
    Cancer; 2018 Sep; 124(17):3586-3595. PubMed ID: 30120912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.
    Yue L; Wentao L; Xin Z; Jingjing H; Xiaoyan Z; Na F; Tonghui M; Dalin L
    Medicine (Baltimore); 2020 Dec; 99(51):e23406. PubMed ID: 33371069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case report: an inextricable shoulder pain as the exclusive presentation of lung adenocarcinoma with metastasis over contralateral clavicle.
    Wu K; Huang YH
    Eur J Med Res; 2021 Feb; 26(1):23. PubMed ID: 33640029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforation of small intestine secondary to metastatic lung adenocarcinoma: A case report.
    Wang J; Chen Y; Zhang S; Chen Q
    Medicine (Baltimore); 2018 Dec; 97(49):e13469. PubMed ID: 30544434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1-ALK fusion.
    Yin Q; Guo T; Zhou Y; Sun L; Meng M; Ma L; Wang X
    Thorac Cancer; 2022 Feb; 13(4):637-642. PubMed ID: 34964276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma.
    Kamide Y; Kaira K; Watanabe T; Kuribayashi S; Ozawa A; Koga Y; Ono A; Sunaga N; Hisada T; Oyama T; Yamada M
    Intern Med; 2015; 54(22):2905-9. PubMed ID: 26568007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.